HTLV-1 INFECTION
Clinical trials for HTLV-1 INFECTION explained in plain language.
Never miss a new study
Get alerted when new HTLV-1 INFECTION trials appear
Sign up with your email to follow new studies for HTLV-1 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare leukemia? drug combo trial launches
Disease control TerminatedThis early-stage trial tests adding lenalidomide to standard chemotherapy (EPOCH) for adult T-cell leukemia-lymphoma, a rare and aggressive blood cancer linked to HTLV-1 infection. The goal is to find the safest dose and see if the combination works better than chemo alone. About…
Matched conditions: HTLV-1 INFECTION
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:38 UTC
-
Researchers track HTLV-1 patients to uncover Long-Term survival trends
Knowledge-focused OngoingThis study follows 69 adults infected with HTLV-1, some of whom have developed a type of blood cancer called adult T-cell leukemia/lymphoma. Researchers are tracking how long participants survive and analyzing their blood and tumor cells to better understand the disease. The goal…
Matched conditions: HTLV-1 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC